Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival. - Test2 - elhamkhani - TriplyDB

Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.

Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.

http://www.wikidata.org/entity/Q37020542

about

The contribution of the ABCG2 C421A polymorphism to cancer susceptibility: a meta-analysis of the current literature.Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy Improving cancer chemotherapy with modulators of ABC drug transporters.A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk.ABCG2 in peptic ulcer: gene expression and mutation analysis Overcoming docetaxel resistance in prostate cancer: a perspective review.MicroRNAs and drug resistance in prostate cancers.Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics.Minireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progression.ABCB1 3435TT and ABCG2 421CC genotypes were significantly associated with longer progression-free survival in Chinese breast cancer patients.

P2860

Q34399824-BA4A5C1B-CFC1-4614-9DE7-27801D426C97 Q35060014-AE26C35D-6F90-4088-8350-5DA97269F6D3 Q36108251-19A3E09F-F649-4A70-8673-C8EE56681237 Q36204229-F2218A20-ABDE-4468-92A2-16FE923A147D Q37131899-398F72A3-B88D-4EBB-AFC8-826D34ED1E1B Q38057235-31C10041-D114-49A9-A3B4-D22D59E468AF Q38205266-B91ED2BD-CC61-4574-B858-9B60CCAE4117 Q38207943-91118FF2-BB73-4389-9005-F0D38D8A798C Q38242231-4939651C-DCBA-4EAF-B0FF-88A140C8B461 Q47552547-37FEDA08-1100-446B-923B-D0AA47B053D3

P2860

Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.

http://www.wikidata.org/entity/Q37020542

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.

@en

Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.

@nl

type

label

Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.

@en

Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.

@nl

prefLabel

Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.

@en

Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.

@nl

P1433

Q37020542-F9DA996B-41C6-4244-981C-386C82CC36C2

P1476

Q37020542-D4898836-320B-4F10-8480-FBCA4115FE93

P2093

Q37020542-0D9FBAD3-3800-416F-B96C-029D7F965CCF

Q37020542-2C757939-F9AC-4DDE-8A49-B7C9B81B6645

Q37020542-61B8355E-8A26-4D00-8C4A-C33F0220C99C

Q37020542-68A09109-A8E5-447A-A1DD-D42EECA0DBC0

Q37020542-8699B9BE-6240-4F10-93E2-3516156EC3E7

Q37020542-8C279546-E47F-4F8B-AFFB-41BDDA24A7F1

Q37020542-A0E1B45D-CFFE-4A50-9004-6B3383BAFBA9

Q37020542-B401BBFC-23D0-4A76-9586-30830DCF680D

Q37020542-C86A5C68-0ECF-452A-9C60-39EFD18F97CC

Q37020542-D9A300B5-DEF1-4B65-BE79-07E1ADBBE41C

P2860

Q37020542-0D5CDEFC-0CE4-4875-8A07-D965C2805B3A

Q37020542-0F61F2B5-143B-4275-A4F7-F05A6C3A2EBA

Q37020542-0FA1B978-0DD5-4B53-A56B-52E995B51F4A

Q37020542-2B93B305-07D1-4058-B296-A271AFCCC8ED

Q37020542-38C02204-E42F-4EF6-8F21-385C8A7E1361

Q37020542-3BACFDC9-C545-45C5-AE08-7AFF2222CB87

Q37020542-3D403458-A78D-4644-B330-4A9A05716E78

Q37020542-48F49B8F-33AF-411F-B5A6-D7F9609B366D

Q37020542-5235D41E-5FC0-4189-9A05-3D3A3B8FDC95

Q37020542-53F878DE-B2BE-4675-83BB-87063A1F8408

P304

Q37020542-3799CF77-7461-4A99-8B7E-B17D21953204

P31

Q37020542-4ECC3CF3-6755-49B5-898F-FF31864052AF

P356

Q37020542-57C1B6C2-05AD-4416-BAA6-14C24477A3DC

P433

Q37020542-16022E9B-4604-4C00-B399-BA23F84FF82C

P478

Q37020542-B8581A33-6B81-4DD9-9D69-B37DE39069F0

P50

Q37020542-E75C5121-A184-4C6A-8F03-0CB80C6E4A00

P577

Q37020542-1AC6BB83-4FA7-41E1-93F2-47889385F499

P698

Q37020542-60B5FD26-FEC1-4099-91E1-8606A6ADCE61

P932

Q37020542-E1749EBF-6BF7-44B5-97D7-2551DC625C06

P356

J.1464-410X.2008.07913.X

P1433

BJU International

P1476

Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival

@en

P2093

Akinobu Hamada

http://www.w3.org/2001/XMLSchema#string

Christoph M Ahlers

http://www.w3.org/2001/XMLSchema#string

Douglas K Price

http://www.w3.org/2001/XMLSchema#string

Erin R Gardner

http://www.w3.org/2001/XMLSchema#string

Sandra B Ockers

http://www.w3.org/2001/XMLSchema#string

Seth M Steinberg

http://www.w3.org/2001/XMLSchema#string

Suneet Shukla

http://www.w3.org/2001/XMLSchema#string

Suresh V Ambudkar

http://www.w3.org/2001/XMLSchema#string

Tristan M Sissung

http://www.w3.org/2001/XMLSchema#string

William D Figg

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular and cellular characterization of ABCG2 in the prostate

Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.

Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity.

ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition.

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

Hormones and prostate cancer: current perspectives and future directions.

Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.

Drug-metabolizing enzymes and transporters: expression in the human prostate and roles in prostate drug disposition.

Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.

Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system.

P304

1694-1699

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2008.07913.X

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18710444

http://www.w3.org/2001/XMLSchema#string

P932

2605573

http://www.w3.org/2001/XMLSchema#string